Article Details
Retrieved on: 2022-02-01 19:55:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The current NCD is evaluating the clinical impact of the class of monoclonal antibodies directed at amyloid plaque in Alzheimer's disease patients ...
Article found on: www.forbes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here